OSH SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Oak Street Health, Inc. and Encourages Long-Term Current Stockholders to Contact the Firm

Philadelphia, Pennsylvania--(Newsfile Corp. - May 17, 2022) - Shareholder protection law firm Kaskela Law LLC announces that it is investigating Oak Street Health, Inc. ("Oak Street" or the "Company") (NYSE: OSH) on behalf of the Company's long-term shareholders.

Recently a securities fraud complaint was filed against Oak Street on behalf of investors who purchased shares of the Company's common stock between August 6, 2020 and November 8, 2021. According to the complaint, during that time period Oak Street made a series of materially false and misleading statements, and failed to disclose material adverse facts to investors, concerning the Company's business, operations, and prospects.

On November 8, 2021, Oak Street disclosed that it had received a civil investigative demand ("CID") from the U.S. Department of Justice. According to the Company's disclosure: (i) "the Department of Justice is investigating whether the Company may have violated the False Claims Act," and (ii) the CID "requests certain documents and information related to the Company's relationships with third-party marketing agents and related to the Company's provision of free transportation to federal health care beneficiaries and requests information and documents related to such matters." Following this news, shares of Oak Street's stock declined $9.75 per share, or 21% in value, to close on November 9, 2021 at $37.14 per share.

Current Oak Street shareholders who purchased or acquired shares of Oak Street's stock prior to November 8, 2021 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq. or Adrienne Bell, Esq.) at (484) 229 - 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/oak-street/ , for additional information about this investigation and their legal rights and options.

Kaskela Law LLC represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about the firm please visit  www.kaskelalaw.com.


D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750

This notice may constitute attorney advertising in certain jurisdictions.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/124257